Navigation Links
Genetic aberration paves the way for new treatment of cancer disease
Date:11/6/2013

12-15 years of development and millions of dollars are typically the costs, when companies develop a new anti-cancer drug. Therefore all short cuts to a treatment are welcome. Researchers at Department of Veterinary Disease Biology, University of Copenhagen, recently discovered such a potential short cut.

"Our new research shows, that we might be able to introduce a treatment faster and cheaper than usual in the development of cancer treatment, and we estimate that it will be efficient in around 10 per cent of patients with colorectal cancer," says MD and PhD student Sune Nygrd, Department of Veterinary Disease Biology, University of Copenhagen.

Re-use of existing breast cancer treatment

In the new study the researchers have shown that around 10 per cent of colorectal cancer patients harbor an aberration in the gene called TOP2A in their cancer cells. These tumors could potentially benefit from treatment with a specific chemotherapeutic drug a so-called "anti-TOP2A treatment", which is already used in breast cancer patients with this gene aberration.

Clinical study begins

Approximately 600,000 patients die of colorectal cancer each year worldwide.

"If the first treatment doesn't cure a patient with colorectal cancer, the possibilities of additional treatment are limited," says Nils Brnner, MD, professor at University of Copenhagen.

"Therefore it is very important to find a new, efficient treatment," he adds.

The research group from the Department of Veterinary Disease Biology and professor Per Pfeiffer at Odense University Hospital have received funds from The Danish Cancer Society to initiate a clinical trial. Here it will be tested, if patients with the TOP2A gene defect could benefit from the targeted anti-TOP2A treatment.

"It is unique to go from a discovery in the laboratory towards a treatment for cancer patients at this pace. This is only possible when researchers and doctors work closely together," says Nils Brnner, University of Copenhagen.


'/>"/>

Contact: Nils Brünner
nbr@sund.ku.dk
45-26-14-47-08
University of Copenhagen
Source:Eurekalert

Related biology news :

1. Genetic study proves Israels wild boars originated in Europe
2. Dolphin genetic study provides revelations
3. Genetic rarity rules in wild guppy population, study finds
4. GenSeq: Updated nomenclature for genetic sequences to solve taxonomic determination issues
5. BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
6. HIV -- Geneticists map human resistance to AIDS
7. Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer
8. Genetic variants associated with bronchodilator responsiveness
9. EUREKA grant to fund development of new optogenetic technique for mapping neural networks at UMMS
10. New software traces origins of genetic disorders 20 times more accurately
11. 2 genetic wrongs make a biochemical right
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... , Dec. 15, 2016 Advancements ... experience, health wellness and wellbeing (HWW), and ... in three new passenger vehicles begin to ... gesture recognition, heart beat monitoring, brain wave ... facial monitoring, and pulse detection. These will ...
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
Breaking Biology News(10 mins):
(Date:1/13/2017)... ... January 13, 2017 , ... FireflySci has been ... found among its diverse customer base. The latest entry in this field is ... including BTX and Bio-Rad. FireflySci is introducing three distinct varieties including a 10x1mm, ...
(Date:1/12/2017)... North Carolina (PRWEB) , ... January 12, 2017 , ... ... called the Eureka Index – a process that evaluates the patent estate of a ... Immunolight LLC , a biomedical firm leading the way in technologies that transform ...
(Date:1/12/2017)... ... 2017 , ... After her brain cancer became resistant to ... a few months to live. Now a paper publishing January 17 in the ... increased both the quantity and quality of her life: Adding the anti-malaria drug ...
(Date:1/12/2017)... Pune, India , January 12, 2017 A new report ... and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that the ... million in 2015, growing at a CAGR of 15.07% during the forecast period. ... ... Research Logo ...
Breaking Biology Technology: